Diagnosis and treatment of autoimmune retinopathy
作者机构:Laboratory of ImmunologyNational Eye InstituteNational Institutes of HealthBethesdaMarylandUSA
出 版 物:《Annals of Eye Science》 (眼科学年鉴(英文))
年 卷 期:2020年第5卷第3期
页 面:56-68页
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题:Autoimmune retinopathy(AIR) cancer-associated retinopathy melanoma-associated retinopathy immunomodulatory therapy
摘 要:Autoimmune retinopathy(AIR)refers to both paraneoplastic and non-paraneoplastic forms of a rare,acquired retinal degeneration thought to be mediated by the production of antiretinal ***,the mechanisms underlying AIR pathogenesis are incompletely understood,and it remains a diagnosis of exclusion given the lack of definitive testing as well as its protean clinical *** review summarizes the current literature on the epidemiology,diagnosis,and management of AIR,with a focus on non-paraneoplastic disease and the potential role of immunomodulatory therapy.A recent expert consensus statement on diagnosis and management of non-paraneoplastic AIR served as a framework for interpreting the limited data available,a process that was complicated by the small sample sizes,heterogeneity,and retrospective nature of these *** work is needed to characterize AIR patients on the basis of cytokine and immunogenetic profiling;to establish the pathogenicity of antiretinal antibodies;and to standardize treatment regimens as well as assessment of clinical outcomes.